B ACUTE LYMPHOBLASTIC LEUKEMIA WITH T(9;22)(Q34.1;Q11.2); BCR-ABL1
Clinical trials for B ACUTE LYMPHOBLASTIC LEUKEMIA WITH T(9;22)(Q34.1;Q11.2); BCR-ABL1 explained in plain language.
Never miss a new study
Get alerted when new B ACUTE LYMPHOBLASTIC LEUKEMIA WITH T(9;22)(Q34.1;Q11.2); BCR-ABL1 trials appear
Sign up with your email to follow new studies for B ACUTE LYMPHOBLASTIC LEUKEMIA WITH T(9;22)(Q34.1;Q11.2); BCR-ABL1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough leukemia cases: gentler treatment trial opens for elderly
Disease control Recruiting nowThis study is testing a combination of a targeted cancer drug (inotuzumab ozogamicin) with lower-intensity chemotherapy and immunotherapy for adults with a type of blood cancer called acute lymphoblastic leukemia (ALL). It focuses on patients aged 60 and older, or younger adults …
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA WITH T(9;22)(Q34.1;Q11.2); BCR-ABL1
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 04, 2026 08:20 UTC
-
Can a common nutrient shield young cancer patients from Chemo's toxic side effects?
Disease control Recruiting nowThis study aims to see if adding a nutrient called levocarnitine to standard chemotherapy can prevent severe liver damage in teenagers and young adults (ages 15-39) being treated for leukemia or lymphoma. A key chemotherapy drug, asparaginase, often causes liver toxicity, which c…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA WITH T(9;22)(Q34.1;Q11.2); BCR-ABL1
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Apr 04, 2026 08:19 UTC
-
New hope for tough blood cancer: trial tests powerful drug cocktail
Disease control Recruiting nowThis study is testing a combination of several chemotherapy drugs, with or without an antibody drug, plus a targeted pill called ponatinib. It aims to see if this approach is safe and effective for adults newly diagnosed with a specific, aggressive form of leukemia or lymphoma. T…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA WITH T(9;22)(Q34.1;Q11.2); BCR-ABL1
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Custom immune cells fight blood cancers after transplant
Disease control Recruiting nowThis study tests a personalized immune cell therapy for patients with blood cancers like leukemia, lymphoma, and myeloma. After receiving chemotherapy and a cord blood transplant, patients get infusions of natural killer (NK) cells—immune cells that may kill remaining cancer cell…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA WITH T(9;22)(Q34.1;Q11.2); BCR-ABL1
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Scientists test new pill cocktail in fight against tough leukemia
Disease control Recruiting nowThis early-stage study is testing the safety and best dose of a new combination of oral pills (venetoclax and dasatinib) for adults with a specific, aggressive type of blood cancer called Philadelphia chromosome positive acute lymphoblastic leukemia (ALL) or mixed phenotype acute…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA WITH T(9;22)(Q34.1;Q11.2); BCR-ABL1
Phase: PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC